Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a single ischemic stroke (a stroke caused by a blocked blood vessel) that was confirmed by brain imaging and resulted in weakness or partial paralysis on one side of the body
- People who are at least six months past their stroke
- People whose arm and hand function falls within a specific range — neither too severely affected nor too mildly affected — as measured by a standard assessment tool at the screening visit (confirm with trial site)
- People who are medically and neurologically stable, based on their medical history and a physical examination
- Women who could potentially become pregnant must have a negative pregnancy test at the start of the study and agree to use appropriate contraception throughout the study
- People who are able to attend sessions three times per week
- People who have enough support from family, friends, or others to participate in all therapy and assessment sessions across eight months
- People who can read, understand, and speak English
Who may not be able to join:
- People who had a hemorrhagic stroke (a stroke caused by bleeding in the brain)
- People who have had more than one stroke
- People who have an active implanted medical device, such as a pacemaker, vagus nerve stimulator, cochlear implant, or a baclofen pump
- People who have significant difficulty communicating that would interfere with taking part in the study
- People who have moderate to severe problems with memory or thinking
- People who have "neglect" — a condition where the brain has difficulty paying attention to or being aware of one side of the body
- People who have severe muscle stiffness (spasticity) in the affected arm
- People who are taking more than 30 mg per day of the muscle relaxant baclofen
- People who changed their baclofen dose within four weeks before enrolling
- People who are currently taking certain medications, including benzodiazepines, dantrolene, tizanidine, blood thinners (anticoagulants), or anti-seizure medications
- People who received botulinum toxin (such as Botox) injections into the muscles of the affected arm within six months before enrolling
- People who have severe joint stiffness or tightening in the affected hand or arm
- People who have had a spontaneous seizure one month or more after their stroke
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chet Moritz, PhD, University of Washington
Phone: 206-787-2692
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline - Fugl-Meyer assessment of the upper limb; Change from baseline - Pinch and grip force; Change from baseline - Modified Ashworth Scale; Change from baseline - Wolf Motor Function Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.